MEDICAL ADVOCATES
WOMEN AND HIV RESOURCE CENTER
  HIV/HPV Coinfection

General Reports
 Risk Factors
 Epidemiology
 Screening/Testing
 Diagnostics
 HPV/Cervical Dysplasia
 HPV/Neoplasia  
Clinical Management



 


 
HIV Coinfections Women Main Page  
Last Update:  November 14, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
     
     Journal Papers, Abstracts, and Commentaries
 
 
Human Papillomavirus Infection and Cervical Disease in Human Immunodeficiency Virus-1-Infected
Women.
 Denny L, Boa R, Williamson AL, et al 
Obstet Gynecol. 2008 Jun;111(6):1380-1387.
 Abstract
 
Frequency, persistence and recurrence of HPV lesions of the uterine cervix in HIV-positive women.
 Berrébi A, Badiou W, Duclusaud A.
Gynecol Obstet Fertil. 2008 May 15.
 Abstract
 
Human papillomavirus vaccines in HIV-positive men and women.
 De Vuyst H, Franceschi S.  
Curr Opin Oncol. 2007 Sep;19(5):470-5.
 Abstract
 
Polymorphism of the L1 Capsid Gene and Persistence of Human Papillomavirus Type 52
Infection in Women at High Risk or Infected by HIV.
Gagnon S, Hankins C, Money D, et al
J Acquir Immune Defic Syndr. 2006 Oct 30;
Abstract
 
Smoking and Time to Clearance of Human Papillomavirus Infection in HIV-Seropositive and
HIV-Seronegative Women.
Koshiol J, Schroeder J, Jamieson DJ, et al 
Am J Epidemiol. 2006 Jun 14
 Abstract
 
Human papillomavirus viral load: a possible marker for cervical disease in HIV-infected women.
Lillo FB, Uberti-Foppa C. 
J Antimicrob Chemother. 2006 Mar 23;
Abstract
 
Human Papillomavirus-related Cervical and Anal Disease in HIV-infected Individuals
in the Era of Highly Active Antiretroviral Therapy.
Piketty C, Kazatchkine MD. 
Curr HIV/AIDS Rep. 2005 Aug;2(3):140-145.
Abstract
 
Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of
HIV-seropositive and HIV-seronegative women at risk for HIV infection.
Gagnon S, Hankins C, Tremblay C, et al ;
J Med Virol. 2005 Feb;75(2):213-21.
 Abstract
 
Human Papillomavirus Capsid Antibody Response to Natural Infection and Risk
of Subsequent HPV Infection in HIV-Positive and HIV-Negative Women.
Viscidi RP, Snyder B, Cu-Uvin S, et al  
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):283-8.
 Abstract
 
Determination of Human Papillomavirus (HPV) Load and Type in High-Grade
Cervical Lesions Surgically Resected from HIV-Infected Women during Follow-up of
HPV Infection.
Lillo FB, Lodini S, Ferrari D, et al   
Clin Infect Dis. 2005 Feb 1;40(3):451-7.
 Abstract

Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of
HIV-seropositive and HIV-seronegative women at risk for HIV infection.
Gagnon S, Hankins C, Tremblay C, et al 
J Med Virol. 2004 Dec 15;75(2):213-221
Abstract

FULL-TEXT ARTICLE
Human papillomavirus type 16 viral load is higher in human immunodeficiency virus-
seropositive women with high-grade squamous intraepithelial lesions than in those
with normal cytology smears.
Lefevre J, Hankins C, Money D, Rachlis A, et al
Clin Microbiol. 2004 May;42(5):2212-5.
Paper
 
Mucosal immune response to Human Papilloma Virus (HPV) infection in HIV positive women.
Agarossi A, Casolati E, Valieri M, et al
Med Wieku Rozwoj. 2003
 Abstract
 
Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women
positive for human immunodeficiency virus in the era of highly active antiretroviral therapy.
Palefsky JM.
Curr Opin Oncol. 2003 Sep;15(5):382-8.
Abstract
 
Factors predicting the persistence of genital human papillomavirus infections and PAP
smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M, Garbuglia AR, Benedetto A, et al
Int J STD AIDS. 2003 Jun;14(6):417-25.
Abstract
 
FULL-TEXT ARTICLE
Human papillomavirus type 16 and immune status in human immunodeficiency virus-
seropositive women.
Strickler HD, Palefsky JM, Shah KV
J Natl Cancer Inst. 2003 Jul 16;95(14):1062-71.
 Paper

     Conference Reports, Abstracts, and Posters  

  Human papillomavirus is associated with HIV acquisition: the EXPLORE study
 P Chin-Hong ,  MHusnik , D Benet, et al
(3rd IAS)
Abstract
Risk Factors
     

     Journal Papers, Abstracts, and Commentaries

 
Effects of Bacterial Vaginosis and Other Genital Infections on the Natural
History of Human Papillomavirus Infection in HIV-1-Infected and High-Risk
HIV-1-Uninfected Women.
Watts DH, Fazarri M, Minkoff H, et al
J Infect Dis. 2005 Apr 1;191(7):1129-39
Abstract

Assessment of risk factors and human papillomavirus (HPV) related pathogenetic
mechanisms of CIN in HIV-positive and HIV-negative women. Study design and
baseline data of the HPV-PathogenISS study.
Branca M, Costa S, Mariani L, et al 
Eur J Gynaecol Oncol. 2004;25(6):689-98.
 Abstract
 

Persistence of human papillomavirus infection in HIV-infected and -uninfected
adolescent girls: risk factors and differences, by phylogenetic type.
Moscicki AB, Ellenberg JH, Farhat S, Xu J.
J Infect Dis. 2004 Jul 1;190(1):37-45.
 Abstract
 
Relationship between smoking and human papillomavirus infections in HIV-infected
and -uninfected women.
Minkoff H, Feldman JG, Strickler HD, et al
J Infect Dis. 2004 May 15;189(10):1821-8.
 Abstract
Epidemiology/Incidence Studies
     

     Journal Papers, Abstracts, and Commentaries

 
HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral
therapy.
 De Vuyst H, Lillo F, Broutet N, Smith JS. 
Eur J Cancer Prev. 2008 Nov;17(6):545-554
 Abstract
 
The prevalence of human papillomavirus (HPV) infection in paired urine and cervical smear
samples of HIV-infected women.
 Jong E, Mulder JW, van Gorp EC,et al
J Clin Virol. 2008 Feb;41(2):111-5.
 Abstract
 
Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African
women prior to antiretroviral therapy.
 Richter KL, van Rensburg EJ, van Heerden WF, Boy SC.
J Oral Pathol Med. 2008 Mar 19
 Abstract
 
Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya.
 De Vuyst H, Gichangi P, Estambale B, et al 
Int J Cancer. 2007 Aug 31;
 Abstract
 
Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions
among high-risk women with and without HIV-1 infection in Burkina Faso.
Didelot-Rousseau MN, Nagot N, Costes-Martineau V, et al
Br J Cancer. 2006 Jul 11;
Abstract
 
Human Papillomavirus (HPV) Detection Among Human Immunodeficiency Virus-Infected
Pregnant Thai Women: Implications for Future HPV Immunization.
Bollen LJ, Chuachoowong R, Kilmarx PH, et al  
Sex Transm Dis. 2006 Jan 13
 Abstract
 
Distribution of human papillomavirus type 16 variants in human immunodeficiency virus
type 1-positive and -negative women.
Chaturvedi AK, Brinkman JA, Gaffga AM, et al
J Gen Virol. 2004 May;85(Pt 5):1237-41.
Abstract
Screening/Testing
     
     Journal Papers, Abstracts, and Commentaries
 
  HPV testing for triage of HIV-infected women with papanicolaou smears read as
atypical squamous cells of uncertain significance.
Massad LS, Schneider MF, Watts DH, et al
J Womens Health (Larchmt). 2004 Mar;13(2):147-53.
Abstract 
 
Relationship between human papilloma virus infection and abnormal Pap smear in
HIV-seropositive women at Siriraj Hospital.
Sirimai K, Sutchritpongsa P, Chaisilwattana P, Laothong K.
J Med Assoc Thai. 2003 Oct;86(10):897-902.
 Abstract
 
Cost effectiveness of human papillomavirus testing to augment cervical
cancer screening in women infected with the human immunodeficiency
virus.
Goldie SJ, Freedberg KA, Weinstein MC
Am J Med 2001 Aug;111(2):140-9
 Abstract
 
     Conference Reports, Abstracts, and Posters  
 
  Impact of HPV DNA testing on a cervical cancer screening program for HIV positive women
 H Sabaka  , J Keller , J Anderson
(16IAC)
 Abstract
Diagnostics
     

     Journal Papers, Abstracts, and Commentaries

 
Contribution of human papillomavirus second-generation hybrid capture test for
the diagnosis of cervical pathology in HIV-infected outpatients.
Sirera G, Videla S, Castella E, et al 
Med Clin (Barc). 2005 Jun 25;125(4):127-31.
 Abstract
 
Contribution of human papillomavirus second-generation hybrid capture test
or the diagnosis of cervical pathology in HIV-infected outpatients.
Sirera G, Videla S, Castella E, et al 
Med Clin (Barc). 2005 Jun 25;125(4):127-31.
Abstract
HPV and Cervical Dysplasia
     


Cervical Dysplasia

     Journal Papers, Abstracts, and Commentaries

  Cervico-vaginal dysplasia-papillomavirus-induced and HIV-1 infection: role of
correlated markers for prognostic evaluation.
Pugliese A, Andronico L, Gennero L, et al.
 Cell Biochem Funct 2002 Sep;20(3):233-6
 Abstract
HPV and Neoplasia
     

     Journal Papers, Abstracts, and Commentaries

 
 
Association of cutaneous anergy with human papillomavirus and cervical neoplasia in
HIV-seropositive and seronegative women.
 Harris TG, Burk RD, Xue X, et al
AIDS. 2007 Sep;21(14):1933-1941.
Abstract
 
Human papillomavirus types in women with invasive cervical carcinoma by HIV status in
Kenya.
 De Vuyst H, Gichangi P, Estambale B, et al
Int J Cancer. 2007 Aug 31;
 Abstract

FULL-TEXT ARTICLE
Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower
genital tract: a review of recent developments.
Ferenczy A, Coutlee F, Franco E, Hankins C.
CMAJ. 2003 Sep 2;169(5):431-4.
 Paper

The interrelation of HIV, cervical human papillomavirus, and neoplasia among
antenatal clinic attenders in Tanzania.
Mayaud P, Gill DK, Weiss HA, et al
Sex Transm Infect 2001 Aug;77(4):248-54
 Abstract
 
FULL-TEXT ARTICLE
Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive
women with high-grade cervical lesions are strongly elevated.
Weissenborn SJ, Funke AM, Hellmich M, et al
J Clin Microbiol. 2003 Jun;41(6):2763-7
 Paper
Clinical Management
     

     Journal Papers, Abstracts, and Commentaries
 
  Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital
lesions in HIV-positive women.
Del Mistro A, Bertorelle R, Franzetti M, et al
Clin Infect Dis. 2004 Mar 1;38(5):737-42.
 Abstract
 
The effect of highly active antiretroviral therapy on cervical cytologic
changes associated with oncogenic HPV among HIV-infected women.
Minkoff H, Ahdieh L, Massad LS, et al
AIDS 2001 Nov 9;15(16):2157-64
 Abstract
 
     Conference Reports, Abstracts, and Posters  
 
  Impact of HIV treatment on clearance of human papillomavirus (HPV) infection in HIV-infected women
Konopnicki D, Manigart Y, Scheen R 
(Ninth International Congress on Drug Therapy in HIV Infection)
 Abstract

HIV Coinfections Women Main Page  

HIV/HPV Coinfection